Pro Feature
Upgrade to Pro to access CMS Part B ASP pricing data and other premium pharma intelligence.
Upgrade to Pro — $25/moCETIRIZINE HYDROCHLORIDE ALLERGY (cetirizine) by Ichnos Glenmark Innovation is histamine h1 receptor antagonists [moa]. Approved for these symptoms due to hay fever, other upper respiratory allergies: runny nose sneezing itchy, watery eyes itching of the nose and 1 more indications. First approved in 2010.
Drug data last refreshed 18h ago
Histamine H1 Receptor Antagonists
Worked on CETIRIZINE HYDROCHLORIDE ALLERGY at Ichnos Glenmark Innovation? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Phase 2 Study IV QUZYTTIR™ (Cetirizine Hydrochloride Injection) vs V Diphenhydramine
Comparing Risk and Severity of IRRs in Patients Premedicated With Cetirizine vs. Diphenhydramine Prior to Ocrelizumab
Cetirizine Chewable Bioequivalence and Food Effect Study
Bioequivalence Study Between Levocetirizine Oral Disintegrating Tablet (ODT) and Levocetirizine Immediate Release Tablet (IRT)
The Effect of Cetirizine on Bronchoconstriction
Upgrade to Pro to access CMS Part B ASP pricing data and other premium pharma intelligence.
Upgrade to Pro — $25/mo